The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...

A 10-day dual regimen of vonoprazan and amoxicillin is noninferior to bismuth quadruple therapy for Helicobacter pylori ...

The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as ...

CPIX reports significant revenue growth and global expansion, while navigating increased expenses and financial commitments.

Vibativ, Sancuso, and new Talicia brand led revenue gains, with initial Talicia sales commencing in Q4. Balance Sheet ...

Good afternoon, and welcome to Cumberland Pharmaceuticals 2025 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on its website for 1 year ...

Gastric cancer remains the fifth leading cause of cancer-related deaths worldwide. Although its overall incidence has declined, early-onset cases-diagnosed before age 50-display unique biological and ...

What patients need to know about omeprazole side effects, as the latest NHS guidance summarised below explains 'red flag' ...

What patients need to know about omeprazole side effects, as the latest NHS guidance summarised below explains 'red flag' symptoms to watch out for. Millions of people take omepra ...

Scientists have found that a common bacterium that usually lives in the mouth can help stomach cancer grow by feeding tumors with a substance they use as fuel. The discovery suggests that this ...

Recently published H. pylori Infections Market Insights report includes a comprehensive understanding of current treatment ...

Kazimi stated, "As we look ahead, we're once again targeting double-digit revenue growth in 2026, driven by the continued performance of our in-line brands combined with the additional sales from the ...